Contact information
Type
Scientific
Primary contact
Dr J.T. van Busschbach
ORCID ID
Contact details
University Medical Centre Groningen
Rob Giel Research Centre
P.O. Box 30001
Groningen
9700 RB
Netherlands
+31 (0)50 361 2069
j.t.van.busschbach@med.umcg.nl
Additional identifiers
EudraCT number
ClinicalTrials.gov number
Protocol/serial number
NTR295
Study information
Scientific title
A randomised controlled trial of the cost-effectiveness of individual placement and support in six European countries
Acronym
EQOLISE
Study hypothesis
Individual placement and supported (IPS) will be cost-effective in achieving regular (open, paid) employment. Differences between countries in the effectiveness of IPS can be explained by socio-economic variables like the employment rate and for instance the existence of a 'benefit trap'.
Ethics approval
Received from the local medical ethics committee
Study design
Multicentre, randomised, active controlled, parallel group trial
Primary study design
Interventional
Secondary study design
Randomised controlled trial
Trial setting
Other
Trial type
Quality of life
Patient information sheet
Condition
Psychiatric, mental disorders/illness
Intervention
Individual placement and support (EXP) will be compared to standard vocational rehabilitation (CC).
Intervention type
Other
Phase
Not Specified
Drug names
Primary outcome measure
1. Achievement of open, paid employment
2. Hours of open employment
3. Time in open employment
Secondary outcome measures
1. Clinical improvement
2. Hospital admissions
3. Unmet needs for care
4. Quality of life
Overall trial start date
01/01/2003
Overall trial end date
01/01/2006
Reason abandoned (if study stopped)
Eligibility
Participant inclusion criteria
1. Diagnosis of a serious mental illness: schizophrenia, schizophrenia-like disorders, bipolar disorder with psychotic features
2. Age 18 - 65 years
3. Living in the community at baseline
4. Not employed for more then a month in the year before the start of the study
5. In mental health care for more then two years
6. Interest in competitive employment
7. Willing to give informed consent
Participant type
Patient
Age group
Adult
Gender
Both
Target number of participants
300
Total final enrolment
312
Participant exclusion criteria
Use of the EXP or CC service in the preceding year
Recruitment start date
01/01/2003
Recruitment end date
01/01/2006
Locations
Countries of recruitment
Netherlands
Trial participating centre
University Medical Centre Groningen
Groningen
9700 RB
Netherlands
Sponsor information
Organisation
University Medical Centre Groningen (UMCG) (The Netherlands)
Sponsor details
Department of General Practice
Hanzeplein 1
Groningen
9713 GZ
Netherlands
Sponsor type
Hospital/treatment centre
Website
Funders
Funder type
Government
Funder name
European Community
Alternative name(s)
Funding Body Type
Funding Body Subtype
Location
Results and Publications
Publication and dissemination plan
Not provided at time of registration
Intention to publish date
Participant level data
Not provided at time of registration
Basic results (scientific)
Publication list
2009 results in: https://www.ncbi.nlm.nih.gov/pubmed/18403375 (added 04/07/2019)